Skip to Main Content

Paper Details

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail.
Nat Microbiol
196
2021
AZD1061, AZD7442, AZD8895, CDRs 1, HCDR3, LCDR1, SARS, SARS-CoV-2, SARS-CoV-2 spike RBD, SARS-CoV-2 spike glycoprotein, complementarity-determining regions, germ, human
Author NameAffiliation
Rita E ChenWashington University School of Medicine
Rita E ChenWashington University School of Medicine
Pavlo GilchukVanderbilt University Medical Center
Xuping XieThe University of Texas Medical Branch at Galveston
Pei-Yong ShiThe University of Texas Medical Branch at Galveston
James LogueThe University of Maryland, College Park
Stuart WestonThe University of Maryland, College Park
Matthew B FriemanThe University of Maryland, College Park
Matthew B FriemanThe University of Maryland, College Park
Robert H CarnahanVanderbilt University Medical Center
Robert H CarnahanVanderbilt University Medical Center
Michael S DiamondWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondAndrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine
James E CroweVanderbilt University Medical Center
James E CroweVanderbilt University Medical Center
James E CroweVanderbilt University Medical Center
  • 1 - 18

Datasets

Release 1.2